{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/692d7130635c16d6404362d8/69cd9f63057b59499579e281?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Market Brief – 1 Apr 2026","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/692d7130635c16d6404362d8/1775079542728-30f5c47d-6bdc-458d-9bb8-17d55881827e.jpeg?height=200","description":"<p>In today’s episode of <em>Market Brief – After Hours</em>, global markets kick off April on a stronger footing as easing oil prices and renewed hopes of de-escalation in the Iran conflict lift sentiment, driving a broad-based relief rally across equities.</p><p>We break down the gains across US markets, with the Dow adding over 200 points, the S&amp;P 500 advancing 0.72%, and the Nasdaq leading with a 1.16% rise as investors rotate back into growth and technology stocks following recent volatility.</p><p>In Europe, markets rebound sharply with strong gains across the STOXX 600, DAX, CAC 40, and FTSE 100, while improving manufacturing data and stabilising sentiment help support the recovery despite lingering macroeconomic concerns.</p><p>Asia-Pacific markets also surge, led by significant rebounds in Japan and South Korea, alongside gains in China, Hong Kong, and Australia, reflecting improved risk appetite as geopolitical tensions show signs of easing.</p><p>The episode also covers detailed Forex technical analysis across EUR/USD, GBP/USD,, USD/CHF, and USD/JPY, highlighting ongoing pressure on European currencies and strong structural support in the US dollar.</p><p>In commodities, oil prices pull back from recent highs while remaining elevated, as Gold extends its recovery above key support levels, reinforcing its role as a safe-haven asset amid ongoing uncertainty.</p><p>In equities, we highlight major movers including a surge in Target Hospitality, gains in nCino and Boeing, and sharp declines in Oric Pharmaceuticals, RH, and Nike.</p>","author_name":"Arshia Hadidi"}